• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    Acorda Therapeutics, Inc. (ACOR)

    38.19 Up 0.13(0.34%) Nov 27, 1:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.4
    Mean Recommendation (last week):2.4

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:44.29
    Median Target:42.00
    High Target:65.00
    Low Target:35.00
    No. of Brokers:7

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 1, 2015Raymond JamesInitiated Mkt Perform
    Jun 9, 2015GuggenheimInitiated Neutral
    Feb 12, 2015MLV & CoInitiated Buy
    Apr 17, 2014Canaccord GenuityInitiated Hold
    Apr 14, 2014FBR CapitalUpgradeMkt PerformOutperform
    Nov 1, 2013MKM PartnersUpgradeSellNeutral
    Oct 30, 2013FBR CapitalInitiated Mkt Perform
    May 2, 2013MKM PartnersDowngradeNeutralSell
    Jan 8, 2013MKM PartnersDowngradeBuyNeutral
    Jan 9, 2012MKM PartnersUpgradeNeutralBuy

    More Upgrades & Downgrades for ACOR

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy1111

    Data provided by Thomson/First Call

    Currency in USD.